Startups

Eyebiotech Limited
Clinical-stage biotechnology company developing therapies for retinal and other sight-threatening eye diseases; acquired by Merck in 2024.
Startups

Clinical-stage biotechnology company developing therapies for retinal and other sight-threatening eye diseases; acquired by Merck in 2024.